Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Lupus Companies

ID: MRFR/Pharma/5173-HCR
90 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Lupus is a chronic autoimmune disease that can affect various parts of the body, causing inflammation and damage to tissues and organs. There are pharmaceutical and biotechnology companies that focus on developing treatments and therapies for lupus.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Lupus Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)10.5%
2025 Market SizeUSD 5.40 Billion
2035 Market SizeUSD 14.05 Billion
Key Players
GSK
AstraZeneca
Aurinia Pharmaceuticals
Roche / Genentech
Bristol-Myers Squibb
Pfizer
Opportunities
  • Precision Biomarker-Guided Therapy Selection
  • Emerging-Market Expansion Through Value-Based Pricing
  • Digital Therapeutics and Remote Disease Monitoring

Top Industry Leaders in the Lupus Market

Lupus Market
ย 

Latestย Lupusย Companiesย Updates:

Vera Therapeutics' fusion protein atacicept received fast track designation from the FDA for the treatment of Systemic Lupus Erythematosus (SLE), indicating a potential new therapeutic option for patients.

Aurinia Pharmaceuticals' Lupkynis (voclosporin) continues to gain market share in the LN (lupus nephritis) segment, offering an alternative to traditional immunosuppressants with potentially fewer side effects.

GlaxoSmithKline (GSK) announced positive Phase 2b results for their anti-IL-17A antibody belimumab in combination with standard therapy for SLE, suggesting potential for enhanced efficacy.

Biogen and Zymeworks collaborate on the development of ZW25, a novel bispecific antibody targeting B-cells and T-cells for potential application in SLE.

CytoDyn and Kiniksa Pharmaceuticals are exploring novel pathways and therapeutics for Lupus treatment, offering hope for personalized medicine approaches.

List ofย Lupusย Key companies in the market:

  • Aurinia Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Cadila Healthcare
  • GlaxoSmithKline plc
  • Mylan N.V.
  • F. Hoffmann-La Roche AG
  • Pfizer